Recipient
The University of British ColumbiaDepartment
National Research Council CanadaAmount
$1.3M
Province
BCType
C
Agreement Number
947806
Purpose
This project will lead to an improved and more cost-effective AAV-LPL gene therapy for the treatment of Lipoprotein Lipase (LPL) Deficiency. The previous limitations of the high costs of production of advanced biologics, such as Glybera, will be addressed through new cost-effective manufacturing in Canada. This project will develop a further optimized AAV-based gene therapy for the treatment of LPL Deficiency as a pilot demonstration of a cost-effective production strategy for new advanced gene therapeutics in Canada.
The University of British Columbia × National Research Council Canada
50 grants totalling $15.4M
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
1,000 grants totalling $348.9M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| The Governing Council of the University of Toronto | $3.0M | Collaborative Science, Technology and In... |